AMYRA Biotech AG is a Swiss based, privately held biotech company that develops novel, enzyme-based treatments for celiac disease and non-celiac gluten sensitivity. AMYRA's patented technology could transform the lives of millions of people around the globe and provide a new gold standard for treating gluten related disorders.
